Related Experiment Video
Updated: Jul 18, 2026

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
Published on: July 25, 2014
Role of CXCR3 and CCR5 in allograft rejection
G T Schnickel1, G R Hsieh, C Garcia
1Division of Cardiac Surgery, Department of Surgery, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California 90095, USA.
Unlabelled:
Chemokines are known to participate in allograft rejection by mediating leukocyte trafficking. Despite redundancy in chemokine family, several chemokine-chemokine receptor interactions have proven critical in alloimmune responses. We sought to determine the effect of combined blockade of CXCR3 and CCR5, two critical chemokine receptors, in acute rejection.
Methods:
Heterotopic heart transplantation was performed using BALB/c to B6/129 mice deficient in CCR5. Following transplantation these mice were treated with goat anti-CXCR3 serum every other day. In the control group, BALB/c hearts were transplanted in wild type B6/129 recipients and treated with goat serum alone. No immunosuppression was given to either group. Recipient mice were then assessed daily for allograft function by abdominal palpation, and graft survival was confirmed by laparotomy.
Results:
The donor hearts in the control group were rejected at 6 +/- 1 days posttransplantation. Combined blockade of CXCR3 and CCR5 prolonged allograft survival versus control; all allografts survived to 24 days. In addition, there was a decrease in graft infiltrating CD4 and CD8 lymphocytes in the experimental group at 24 days.
Conclusion:
Combined CXCR3 and CCR5 blockade is effective in prolonging allograft survival in a fully MHC mismatched murine model. Combined chemokine blockade holds promise in control of acute rejection in organ transplantation.
Insights
Blocking CXCR3 and CCR5 receptors significantly extended heart transplant survival in mice. This combined chemokine receptor blockade reduced immune cell infiltration, offering a promising strategy for controlling acute organ transplant rejection.
Area of Science:
- Immunology
- Transplantation Biology
- Molecular Medicine
Background:
- Chemokines mediate leukocyte trafficking and play a critical role in allograft rejection.
- Specific chemokine-chemokine receptor interactions are vital in alloimmune responses, despite functional redundancy within the chemokine family.
Purpose of the Study:
- To investigate the therapeutic potential of simultaneously blocking CXCR3 and CCR5 in acute allograft rejection.
- To evaluate the impact of combined chemokine receptor blockade on immune cell infiltration and graft survival.
Main Methods:
- A heterotopic heart transplantation model was established using CCR5-deficient mice undergoing transplantation from BALB/c to B6/129 recipients.
- Experimental group mice received anti-CXCR3 serum, while controls received non-specific goat serum, without additional immunosuppression.
- Allograft function was monitored daily via palpation, with graft survival confirmed by laparotomy.
Main Results:
- Control group allografts were rejected rapidly, within 6 ± 1 days post-transplantation.
- Combined blockade of CXCR3 and CCR5 significantly prolonged allograft survival, with all grafts surviving up to 24 days.
- A notable decrease in CD4 and CD8 lymphocyte infiltration into the graft was observed in the experimental group at 24 days.
Conclusions:
- Simultaneous blockade of CXCR3 and CCR5 effectively prolongs allograft survival in a fully MHC-mismatched murine model.
- Combined chemokine receptor blockade demonstrates significant promise as a strategy to manage acute rejection in organ transplantation.
Related Concept Videos
Cell-mediated Immune Responses
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...